Hemostatic drugs in trauma and orthopedic practice

Seminars in Anesthesia

Volumn 20, Issue 1, 2001, Pages 18-23

  Royston, David ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; HEMOSTATIC AGENT;

ANTIINFLAMMATORY ACTIVITY; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HEMOSTASIS; HUMAN; INJURY; MEDICAL PRACTICE; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SOFT TISSUE INJURY; TOTAL HIP PROSTHESIS;

EID: 0035107564     PISSN: 02770326     EISSN: None     Source Type: Journal    
DOI: 10.1053/sane.2001.21093     Document Type: Article

References (40)

1. Feasibility study of very high aprotinin dosage in polytrauma patients
2. Aprotinin: A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery
3. High-dose aprotinin therapy: A review of the first five years' experience
4. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery
5. Blood loss and transfusion requirements in total joint arthroplasty
6. Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators
7. Hemostatic drugs
8. Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients treated with aspirin
9. Use of desmopressin (DDAVP) in controlling aspirin-induced coagulopathy after cardiac surgery
10. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction
11. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: A prospective, randomised, double-blind study of 86 patients
12. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty
13. The effect of aprotinin on platelet function, blood coagulation and blood lactate level in total hip replacement - A double blind clinical trial
14. The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery
15. Effect of aprotinin on thrombocytic function during total endoprosthesis surgery of the hip
16. Aprotinin 2 million KIU reduces perioperative blood loss in patients undergoing primary total hip replacement
17. High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery
18. Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement
19. Aprotinin versus lysine analogues: The debate continues
20. Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicentre randomised double-blind study. EMSALT Study Group
21. Aprotinin decreases blood loss and homologous transfusions in patients undergoing major orthopedic surgery
22. Aprotinin reduces intraoperative bleeding during spinal arthrodesis interventions
23. Importance of fibrinolysis in limiting thrombus formation following severe microarterial trauma: An experimental study in the rabbit
24. Vasoactive agents and production of thrombosis during intravascular coagulation 1 - Comparative effects of norepinephrine in thrombin and adenosine diphosphate (ADP) treated rabbits
25. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thrombin
26. Aprotinin prevents the development of the trauma-induced multiple organ failure in a chronic sheep model
27. Early changes of the coagulation system in multiple injuries and their modification with heparin and trasylol
28. Results of a field study on the therapeutic value of aprotinin in traumatic shock
29. Randomized blinded study of aprotinin infusion for liver crush injuries in the pig model
30. Aprotinin reduces blood loss in patients undergoing elective liver resection
31. Preventing the inflammatory response to open-heart surgery: The role of aprotinin and other protease inhibitors
32. Fat embolism and proteinase inhibitors
33. Fat embolism: Physiopathology, diagnosis with management
34. Postoperative increase in lactate in total hip endoprosthesis operations. Effect of aprotinin. Results of a clinical double-blind study
35. Effect of aprotinin on metabolic changes in blood following aortofemoral bypass operation
36. A double blind clinical trial to assess the value of aprotinin in third molar surgery
37. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis
38. Purification and characterisation of 6 and 58 kDa forms of the endogenous serine proteinase inhibitory proteins of ovine articular cartilage
39. Infiltrations in gonarthrosis, a therapeutic turning point: The use of a proteinase inhibitor
40. Reduction of restrictive adhesions by local aprotinin application and primary sheath repair in surgically traumatized flexor tendons of the rabbit